BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34064480)

  • 21. Ebolavirus Glycoprotein Fc Fusion Protein Protects Guinea Pigs against Lethal Challenge.
    Konduru K; Shurtleff AC; Bradfute SB; Nakamura S; Bavari S; Kaplan G
    PLoS One; 2016; 11(9):e0162446. PubMed ID: 27622456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Antibodies to VP4 Inhibit Replication of Enteroviruses Across Subgenotypes and Serotypes, and Enhance Host Innate Immunity.
    Phanthong S; Densumite J; Seesuay W; Thanongsaksrikul J; Teimoori S; Sookrung N; Poovorawan Y; Onvimala N; Guntapong R; Pattanapanyasat K; Chaicumpa W
    Front Microbiol; 2020; 11():562768. PubMed ID: 33101238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
    Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
    PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-Mediated Protective Mechanisms Induced by a Trivalent Parainfluenza Virus-Vectored Ebolavirus Vaccine.
    Kimble JB; Malherbe DC; Meyer M; Gunn BM; Karim MM; Ilinykh PA; Iampietro M; Mohamed KS; Negi S; Gilchuk P; Huang K; Wolf YI; Braun W; Crowe JE; Alter G; Bukreyev A
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human monoclonal ScFv that inhibits cellular entry and metalloprotease activity of tetanus neurotoxin.
    Indrawattana N; Sookrung N; Kulkeaw K; Seesuay W; Kongngoen T; Chongsa-nguan M; Tungtrongchitr A; Chaicumpa W
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):85-93. PubMed ID: 20527521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Single-Chain Antibodies That Neutralize Elastolytic Activity of
    Santajit S; Kong-Ngoen T; Chongsa-Nguan M; Boonyuen U; Pumirat P; Sookrung N; Chaicumpa W; Indrawattana N
    Pathogens; 2021 Jun; 10(6):. PubMed ID: 34204417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Filoviruses Use the HOPS Complex and UVRAG To Traffic to Niemann-Pick C1 Compartments during Viral Entry.
    Bo Y; Qiu S; Mulloy RP; Côté M
    J Virol; 2020 Jul; 94(16):. PubMed ID: 32493822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.
    Keck ZY; Enterlein SG; Howell KA; Vu H; Shulenin S; Warfield KL; Froude JW; Araghi N; Douglas R; Biggins J; Lear-Rooney CM; Wirchnianski AS; Lau P; Wang Y; Herbert AS; Dye JM; Glass PJ; Holtsberg FW; Foung SK; Aman MJ
    J Virol; 2016 Jan; 90(1):279-91. PubMed ID: 26468532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An exploration of conditions proposed to trigger the Ebola virus glycoprotein for fusion.
    Fénéant L; Szymańska-de Wijs KM; Nelson EA; White JM
    PLoS One; 2019; 14(7):e0219312. PubMed ID: 31276481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Hyperstabilizing Mutation in the Base of the Ebola Virus Glycoprotein Acts at Multiple Steps To Abrogate Viral Entry.
    Fels JM; Spence JS; Bortz RH; Bornholdt ZA; Chandran K
    mBio; 2019 Jul; 10(4):. PubMed ID: 31289183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
    González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Broad Neutralizing Activity Against Ebolaviruses Lacking the Mucin-Like Domain in Convalescent Plasma Specimens From Patients With Ebola Virus Disease.
    Luczkowiak J; Lasala F; Mora-Rillo M; Arribas JR; Delgado R
    J Infect Dis; 2018 Nov; 218(suppl_5):S574-S581. PubMed ID: 29939289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
    Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
    Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of a Large Single-Chain 13F6 Antibody with Binding Activity against Ebola Virus-Like Particles in a Plant System.
    Lim S; Kim DS; Ko K
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-Exposure Protection in Mice against Sudan Virus by a Two Antibody Cocktail.
    Froude JW; Herbert AS; Pelat T; Miethe S; Zak SE; Brannan JM; Bakken RR; Steiner AR; Yin G; Hallam TJ; Sato AK; Hust M; Thullier P; Dye JM
    Viruses; 2018 May; 10(6):. PubMed ID: 29861435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein.
    Liu JL; Shriver-Lake LC; Anderson GP; Zabetakis D; Goldman ER
    Microb Cell Fact; 2017 Dec; 16(1):223. PubMed ID: 29233140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicular Stomatitis Virus Pseudotyped with Ebola Virus Glycoprotein Serves as a Protective, Noninfectious Vaccine against Ebola Virus Challenge in Mice.
    Lennemann NJ; Herbert AS; Brouillette R; Rhein B; Bakken RA; Perschbacher KJ; Cooney AL; Miller-Hunt CL; Ten Eyck P; Biggins J; Olinger G; Dye JM; Maury W
    J Virol; 2017 Sep; 91(17):. PubMed ID: 28615211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.
    Rhein BA; Brouillette RB; Schaack GA; Chiorini JA; Maury W
    J Virol; 2016 Jul; 90(13):6097-6111. PubMed ID: 27122575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of Cell-Cell Fusion by Ebola Virus Glycoprotein: Low pH Is Not a Trigger.
    Markosyan RM; Miao C; Zheng YM; Melikyan GB; Liu SL; Cohen FS
    PLoS Pathog; 2016 Jan; 12(1):e1005373. PubMed ID: 26730950
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human scFvs That Counteract Bioactivities of Staphylococcus aureus TSST-1.
    Rukkawattanakul T; Sookrung N; Seesuay W; Onlamoon N; Diraphat P; Chaicumpa W; Indrawattana N
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28218671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.